BioSpace News Archive

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, released today the concluding results of its in-vivo study evaluating the efficacy of the company’s proprietary drug candidate RCC-33 in prolonging survival rate in mice

PPD Named a Leader in Digital Clinical Trial Solutions by ISG Recognized for comprehensive strengths in the design, deployment of decentralized solutions

EnPro Industries, Inc. (NYSE: NPO) will present at Sidoti’s Spring 2021 Virtual Conference on Wednesday, March 24. The company’s presentation is scheduled for 1:00 p.m. Eastern Time and will be made by Marvin Riley, president and chief executive officer, and Milt Childress, executive vice president and chief financial officer.

Monocent Inc., (Monocent) is pleased to announce the COFEPRIS authorization of their SARS-CoV2 Antigen Rapid test System for detection of COVID-19 infection. The Monocent antigen test is a lateral flow test that provides results in just 15-minutes, without the use of any laboratory equipment.

Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused by Meibomian Gland Dysfunction (MGD).

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced findings from a new analysis evaluating the impact of symptom progression on the ability of people with amyotrophic lateral sclerosis (ALS)

Carium, a leader in telehealth technology, today announces the success of Health Logx’s virtual care program. Health Logx partners with primary care practices to provide virtual health and wellness services for at-risk patients, focusing on the CMS programs of remote patient monitoring (RPM) and chronic care management (CCM) to virtually support patients in between office visits.

Signati Medical Inc. is pleased to announce the following doctors have joined their Clinical Advisory Board: Dr. Gerard Henry, MD; Dr. Tariq S. Hakky, MD; Dr. Rahul Mehan, MD; Dr. Michel Labrecque, MD, PhD; Dr. Joel L. Marmar, MD.

Children’s Hospital of Philadelphia announced that Tyra Bryant-Stephens, M.D. has been appointed Senior Director of its Center for Health Equity.

M2GEN today announced a significant new investment by Clayton, Dubilier & Rice (“CD&R”) funds, the Merck Global Health Innovation Fund (“Merck GHI”), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care, in partnership with its existing shareholders